Coloplast As Sp/Adr (CLPBY) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Coloplast A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.798 Ladies and gentlemen, welcome to the Coloplast financial statement for the full year 00:00:04.798 -- 00:00:06.741 2024-2025 00:00:06.741 -- 00:00:09.586 and annual report 2024-2025 00:00:09.586 -- 00:00:14.013 conference call. I am Sandra, the course call operator. 00:00:14.013 -- 00:00:17.899 I would like to remind you that all participants have been disanonymized and the conference 00:00:17.899 -- 00:00:22.807 has been recorded. The presentation will be followed by a Q&A session. 00:00:22.807 -- 00:00:28.145 You can register for questions at any time by pressing star and one on your telephone. 00:00:28.145 -- 00:00:31.832 For operator assistance, please press star and zero. 00:00:31.832 -- 00:00:35.519 The conference must not be recorded for publication or broadcast. 00:00:35.519 -- 00:00:40.289 At this time, it's my pleasure to hand over to Lars Rasmussen, Interim CEO. 00:00:40.289 -- 00:00:42.151 Please go ahead. 00:00:42.151 -- 00:00:47.821 Thank you and good morning and welcome to our full year 24-25 conference call. 00:00:47.821 -- 00:00:52.550 I'm Lars Rasmussen, interim CEO of Coloplast and I'm joined by Anders Lonning-Skovgaard, 00:00:52.550 -- 00:00:55.755 our CFO and by our investor relations team. 00:00:55.755 -- 00:01:00.944 We will start with a short presentation by Anders and myself and then open up for questions. 00:01:00.944 -- 00:01:03.953 Please turn to slide number three. 00:01:03.953 -- 00:01:09.002 We delivered 7% organic growth and a reported EBIT margin before 00:01:09.002 -- 00:01:13.387 special items of 28% for this financial year. 00:01:13.831 -- 00:01:19.021 That is in line with our revised guidance, but below the 8-9% organic growth expectations 00:01:19.021 -- 00:01:21.786 that we set forth at the beg...